OTC · Financial Statements
LakeShore Biopharma Co., Ltd (LSBCF) Financial Statements
$0.07
OTC: LSBCF
Market Cap $2.76M
Overview Financials Dividend
LakeShore Biopharma Co., Ltd most recently reported annual revenue of $615.0M, a net loss of $100.0M. Revenue grew at an average annual rate of 24.4% over the last 4 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $257.0M $503.0M $687.0M $573.0M $615.0M Operating Profit $-126.0M $-119.0M $-139.0M $-446.0M $-86.0M Net Profit $-192.0M $-237.0M $-145.0M $-433.0M $-100.0M EPS $-6.67 $-0.02 $-1.88 $-4.05 $-0.94 Op Margin -49.0% -23.6% -20.3% -77.8% -14.0%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $0 $201.0M $1.7B $1.5B $1.4B Total Liabilities $0 $20.0M $991.0M $928.0M $868.0M Cash $390.0M $271.0M $370.0M $246.0M $28.0M Borrowings $19.0M $381.0M $499.0M $424.0M $414.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-247.0M $-1.0M $-182.0M $-295.0M $-121.0M Investing Cash Flow $-209.0M $-598.0M $-114.0M $-89.0M $-35.0M Financing Cash Flow $0 $0 $217.0M $0 $0 Net Cash Flow $388.0M $-119.0M $99.0M $-124.0M $-139.0M Free Cash Flow $-351.0M $-300.0M $-240.0M $-339.0M $-139.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.01 EV / EBITDA -8.34 FCF Yield -743.60% Quick Ratio 0.75 Interest Coverage -5.48 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .